GEMODIVEQ Trademark

Trademark Overview

On Tuesday, May 5, 2020, a trademark application was filed for GEMODIVEQ with the United States Patent and Trademark Office. The USPTO has given the GEMODIVEQ trademark a serial number of 88902185. The federal status of this trademark filing is REGISTERED as of Tuesday, November 7, 2023. This trademark is owned by Pfizer Inc.. The GEMODIVEQ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of genetic diseases and disorders; pharmaceutical preparations for the treatment of muscular dystrophy
gemodiveq

General Information

Serial Number88902185
Word MarkGEMODIVEQ
Filing DateTuesday, May 5, 2020
Status700 - REGISTERED
Status DateTuesday, November 7, 2023
Registration Number7213583
Registration DateTuesday, November 7, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 4, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of genetic diseases and disorders; pharmaceutical preparations for the treatment of muscular dystrophy

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, May 17, 2020
Primary Code005
First Use Anywhere DateThursday, August 31, 2023
First Use In Commerce DateThursday, August 31, 2023

Trademark Owner History

Party NamePfizer Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew York, NY 100012192
Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 100012192
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Tuesday, November 7, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, November 7, 2023REGISTERED-PRINCIPAL REGISTER
Thursday, October 5, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, October 4, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, October 3, 2023STATEMENT OF USE PROCESSING COMPLETE
Wednesday, September 27, 2023USE AMENDMENT FILED
Wednesday, September 27, 2023TEAS STATEMENT OF USE RECEIVED
Thursday, April 6, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, April 6, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 6, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, April 6, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, April 6, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, March 1, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 28, 2023SOU EXTENSION 5 GRANTED
Friday, February 10, 2023SOU EXTENSION 5 FILED
Tuesday, February 28, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, February 10, 2023SOU TEAS EXTENSION RECEIVED
Saturday, September 10, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 8, 2022SOU EXTENSION 4 GRANTED
Thursday, September 8, 2022SOU EXTENSION 4 FILED
Thursday, September 8, 2022SOU TEAS EXTENSION RECEIVED
Saturday, March 19, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 17, 2022SOU EXTENSION 3 GRANTED
Thursday, March 17, 2022SOU EXTENSION 3 FILED
Thursday, March 17, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, September 15, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 13, 2021SOU EXTENSION 2 GRANTED
Monday, September 13, 2021SOU EXTENSION 2 FILED
Monday, September 13, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, March 2, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 26, 2021SOU EXTENSION 1 GRANTED
Friday, February 26, 2021SOU EXTENSION 1 FILED
Friday, February 26, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, September 29, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 4, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 4, 2020PUBLISHED FOR OPPOSITION
Wednesday, July 15, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, June 25, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 23, 2020ASSIGNED TO EXAMINER
Sunday, May 17, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, May 8, 2020NEW APPLICATION ENTERED

Related Keywords

gemodiveq pharmaceutical treatment preparations dystrophy muscular genetic diseases disorders